文献速递关节外科

全髋关节置换术后患者寿命是否更长,且相对生存率是否因诊断而异?

Do Patients Live Longer After THA and Is the Relative Survival Diagnosis-specific?
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

基于瑞典髋关节置换登记系统1999年1月1日至2012年12月31日131808例全髋关节置换(THA)患者(随访末21755例死亡),并以瑞典全国人群年龄性别匹配生存数据为参照,发现择期THA患者术后约10年内相对生存率略优于一般人群;以原发性骨关节炎为参照,股骨头坏死、炎性关节炎和继发性骨关节炎患者相对生存率较差,儿童髋病后遗症患者相似。

要点

  • 择期THA患者术后约10年内相对生存率略优于一般人群,12年时无差异。
  • 以原发性骨关节炎为参照,股骨头坏死、炎性关节炎和继发性骨关节炎患者相对生存率较差。
  • 儿童髋病后遗症患者相对生存率与原发性骨关节炎相似。

核心结论

  • 本研究表明THA与术后约10年的略增预期寿命相关,尤其在原发性骨关节炎患者中,这进一步证明了该手术干预的健康经济价值。
  • 相对生存率增加的原因尚不清楚,可能是多因素的。

研究设计与样本

  • 研究使用瑞典髋关节置换登记系统数据,并与行政健康数据库链接。
  • 共识别1999年1月1日至2012年12月31日期间接受THA的131808例患者,其中21755例在随访结束时死亡。
  • 患者和手术特异性数据结合社会经济数据可供分析;采用年龄和性别匹配的瑞典全国人群生存数据(根据瑞典统计局)比较相对生存率。
  • 使用变换时间下的Cox比例风险模型进行多变量建模。
  • 证据等级为III级,治疗性研究。

主要发现

  • 择期THA患者术后约10年内相对生存率略优于一般人群;术后1年THA患者生存率比预期好1%(r=1.01;95%CI,1.01-1.02;p<0.001);5年增至3%(r=1.03;95%CI,1.03-1.03;p<0.001);10年差异为2%(r=1.02;95%CI,1.02-1.03;p<0.001);12年时THA患者与一般人群无差异(r=1.01;95%CI,0.99-1.02;p=0.13)。
  • 以原发性骨关节炎为参照,儿童髋病后遗症患者相对生存率相似(HR,1.02;95%CI,0.88-1.18;p=0.77)。
  • 股骨头坏死(HR,1.69;95%CI,1.60-1.79;p<0.001)、炎性关节炎(HR,1.49;95%CI,1.38-1.61;p<0.001)和继发性骨关节炎(HR,2.46;95%CI,2.03-2.99;p<0.001)患者相对生存率较差。
  • 合并症和Elixhauser合并症指数与相对生存率负相关。
  • 教育水平(中等教育水平:HR,0.90;95%CI,0.87-0.93;p<0.001;高水平:HR,0.76;95%CI,0.73-0.80;p<0.001)和婚姻状况(单身状态:HR,1.33;95%CI,1.28-1.38;p<0.001)也与生存率负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hip replacements are successful in restoring mobility, reducing pain, and improving quality of life. However, the association between THA and the potential for increased life expectancy (as expressed by mortality rate) is less clear, and any such association could well be influenced by diagnosis and patient-related, socioeconomic, and surgical factors, which have not been well studied. QUESTIONS/PURPOSES: (1) After controlling for birth year and sex, are Swedish patients who underwent THA likely to survive longer than individuals in the general population? (2) After controlling for relevant patient-related, socioeconomic/demographic factors and surgical factors, does relative survival differ across the various diagnoses for which THAs were performed in Sweden? METHODS: Data from the Swedish Hip Arthroplasty Register, linked to administrative health databases, were used for this study. We identified 131,808 patients who underwent THA between January 1, 1999, and December 31, 2012. Of these, 21,755 had died by the end of followup. Patient- and surgery-specific data in combination with socioeconomic data were available for analysis. We compared patient survival (relative survival) with age- and sex-matched survival data in the entire Swedish population according to Statistics Sweden. We used multivariable modeling proceeded with a Cox proportional hazards model in transformed time. RESULTS: Patients undergoing elective THA had a slightly improved survival rate compared with the general population for approximately 10 years after surgery. At 1 year after surgery, the survival in patients undergoing THA was 1% better than the expected survival (r = 1.01; 95% confidence interval [CI], 1.01-1.02; p < 0.001); at 5 years, this increased to 3% (r = 1.03; 95% CI, 1.03-1.03; p < 0.001); at 10 years, the difference was 2% (r = 1.02; 95% CI, 1.02-1.03; p < 0.001); and by 12 years, there was no difference between patients undergoing THA and the general population (r = 1.01; 95% CI, 0.99-1.02; p = 0.13). Using the diagnosis of primary osteoarthritis as a reference, hip arthroplasties performed for sequelae of childhood hip diseases had a similar survival rate (hazard ratio [HR], 1.02; 95% CI, 0.88-1.18; p = 0.77). Patients undergoing surgery for osteonecrosis of the femoral head (HR, 1.69; 95% CI, 1.60-1.79; p < 0.001), inflammatory arthritis (HR, 1.49; 95% CI, 1.38-1.61; p < 0.001), and secondary osteoarthritis (HR, 2.46; 95% CI, 2.03-2.99; p < 0.001) all had poorer relative survival. Comorbidities and the Elixhauser comorbidity index had a negative association with relative survival. Level of achieved education (middle level of education: HR, 0.90, 95% CI, 0.87-0.93, p < 0.001; high level: 0.76, 95% CI, 0.73-0.80, p < 0.001) and marital status (single status: HR, 1.33; 95% CI, 1.28-1.38; p < 0.001) were also negatively associated with survival. CONCLUSIONS: Whereas it has been known that in most patients, THA improves quality of life, this study demonstrates that it also is associated with a slightly increased life expectancy that lasts for approximately 10 years after surgery, especially among patients whose diagnosis was primary osteoarthritis. This adds further proof of a health-economic value for this surgical intervention. The reasons for the increase in relative survival are unknown but are probably multifactorial. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Cnudde P, Rolfson O, Timperley AJ, et al. Do Patients Live Longer After THA and Is the Relative Survival Diagnosis-specific? Clin Orthop Relat Res. 2018. PMID: 29489471. doi:10.1007/s11999.0000000000000097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。